pVITRO1-Trastuzumab-IgG2/κ Citations (1)
Originally described in: A tool kit for rapid cloning and expression of recombinant antibodies.Dodev TS, Karagiannis P, Gilbert AE, Josephs DH, Bowen H, James LK, Bax HJ, Beavil R, Pang MO, Gould HJ, Karagiannis SN, Beavil AJ Sci Rep. 2014 Jul 30;4:5885. doi: 10.1038/srep05885. PubMed Journal
Articles Citing pVITRO1-Trastuzumab-IgG2/κ
Articles |
---|
The hinge-engineered IgG1-IgG3 hybrid subclass IgGh(47) potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies. Izadi A, Karami Y, Bratanis E, Wrighton S, Khakzad H, Nyblom M, Olofsson B, Happonen L, Tang D, Sundwall M, Godzwon M, Chao Y, Toledo AG, Schmidt T, Ohlin M, Nilges M, Malmstrom J, Bahnan W, Shannon O, Malmstrom L, Nordenfelt P. Nat Commun. 2024 Apr 27;15(1):3600. doi: 10.1038/s41467-024-47928-8. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.